Specifically, among women with CHD, those with elevated sFlt-1 had a significantly higher incidence of adverse outcomes, whereas those with low PlGF or a high sFlt-1/PlGF ratio showed only a nonsignificant trend toward increased risk. Here, PGF is linked to coronary artery disorder.